Cargando…
The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence
BACKGROUND: There are no commercially available vaccines against human protozoan parasitic diseases, despite the success of vaccination-induced long-term protection against infectious diseases. East Coast fever, caused by the protist Theileria parva, kills one million cattle each year in sub-Saharan...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583173/ https://www.ncbi.nlm.nih.gov/pubmed/26403690 http://dx.doi.org/10.1186/s12864-015-1910-9 |
_version_ | 1782391804862136320 |
---|---|
author | Norling, Martin Bishop, Richard P. Pelle, Roger Qi, Weihong Henson, Sonal Drábek, Elliott F. Tretina, Kyle Odongo, David Mwaura, Stephen Njoroge, Thomas Bongcam-Rudloff, Erik Daubenberger, Claudia A. Silva, Joana C. |
author_facet | Norling, Martin Bishop, Richard P. Pelle, Roger Qi, Weihong Henson, Sonal Drábek, Elliott F. Tretina, Kyle Odongo, David Mwaura, Stephen Njoroge, Thomas Bongcam-Rudloff, Erik Daubenberger, Claudia A. Silva, Joana C. |
author_sort | Norling, Martin |
collection | PubMed |
description | BACKGROUND: There are no commercially available vaccines against human protozoan parasitic diseases, despite the success of vaccination-induced long-term protection against infectious diseases. East Coast fever, caused by the protist Theileria parva, kills one million cattle each year in sub-Saharan Africa, and contributes significantly to hunger and poverty in the region. A highly effective, live, multi-isolate vaccine against T. parva exists, but its component isolates have not been characterized. Here we sequence and compare the three component T. parva stocks within this vaccine, the Muguga Cocktail, namely Muguga, Kiambu5 and Serengeti-transformed, aiming to identify genomic features that contribute to vaccine efficacy. RESULTS: We find that Serengeti-transformed, originally isolated from the wildlife carrier, the African Cape buffalo, is remarkably and unexpectedly similar to the Muguga isolate. The 420 detectable non-synonymous SNPs were distributed among only 53 genes, primarily subtelomeric antigens and antigenic families. The Kiambu5 isolate is considerably more divergent, with close to 40,000 SNPs relative to Muguga, including >8,500 non-synonymous mutations distributed among >1,700 (42.5 %) of the predicted genes. These genetic markers of the component stocks can be used to characterize the composition of new batches of the Muguga Cocktail. CONCLUSIONS: Differences among these three isolates, while extensive, represent only a small proportion of the genetic variation in the entire species. Given the efficacy of the Muguga Cocktail in inducing long-lasting protection against infections in the field, our results suggest that whole-organism vaccines against parasitic diseases can be highly efficacious despite considerable genome-wide differences relative to the isolates against which they protect. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-015-1910-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4583173 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45831732015-09-26 The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence Norling, Martin Bishop, Richard P. Pelle, Roger Qi, Weihong Henson, Sonal Drábek, Elliott F. Tretina, Kyle Odongo, David Mwaura, Stephen Njoroge, Thomas Bongcam-Rudloff, Erik Daubenberger, Claudia A. Silva, Joana C. BMC Genomics Research Article BACKGROUND: There are no commercially available vaccines against human protozoan parasitic diseases, despite the success of vaccination-induced long-term protection against infectious diseases. East Coast fever, caused by the protist Theileria parva, kills one million cattle each year in sub-Saharan Africa, and contributes significantly to hunger and poverty in the region. A highly effective, live, multi-isolate vaccine against T. parva exists, but its component isolates have not been characterized. Here we sequence and compare the three component T. parva stocks within this vaccine, the Muguga Cocktail, namely Muguga, Kiambu5 and Serengeti-transformed, aiming to identify genomic features that contribute to vaccine efficacy. RESULTS: We find that Serengeti-transformed, originally isolated from the wildlife carrier, the African Cape buffalo, is remarkably and unexpectedly similar to the Muguga isolate. The 420 detectable non-synonymous SNPs were distributed among only 53 genes, primarily subtelomeric antigens and antigenic families. The Kiambu5 isolate is considerably more divergent, with close to 40,000 SNPs relative to Muguga, including >8,500 non-synonymous mutations distributed among >1,700 (42.5 %) of the predicted genes. These genetic markers of the component stocks can be used to characterize the composition of new batches of the Muguga Cocktail. CONCLUSIONS: Differences among these three isolates, while extensive, represent only a small proportion of the genetic variation in the entire species. Given the efficacy of the Muguga Cocktail in inducing long-lasting protection against infections in the field, our results suggest that whole-organism vaccines against parasitic diseases can be highly efficacious despite considerable genome-wide differences relative to the isolates against which they protect. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-015-1910-9) contains supplementary material, which is available to authorized users. BioMed Central 2015-09-24 /pmc/articles/PMC4583173/ /pubmed/26403690 http://dx.doi.org/10.1186/s12864-015-1910-9 Text en © Norling et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Norling, Martin Bishop, Richard P. Pelle, Roger Qi, Weihong Henson, Sonal Drábek, Elliott F. Tretina, Kyle Odongo, David Mwaura, Stephen Njoroge, Thomas Bongcam-Rudloff, Erik Daubenberger, Claudia A. Silva, Joana C. The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence |
title | The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence |
title_full | The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence |
title_fullStr | The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence |
title_full_unstemmed | The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence |
title_short | The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence |
title_sort | genomes of three stocks comprising the most widely utilized live sporozoite theileria parva vaccine exhibit very different degrees and patterns of sequence divergence |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583173/ https://www.ncbi.nlm.nih.gov/pubmed/26403690 http://dx.doi.org/10.1186/s12864-015-1910-9 |
work_keys_str_mv | AT norlingmartin thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT bishoprichardp thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT pelleroger thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT qiweihong thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT hensonsonal thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT drabekelliottf thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT tretinakyle thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT odongodavid thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT mwaurastephen thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT njorogethomas thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT bongcamrudlofferik thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT daubenbergerclaudiaa thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT silvajoanac thegenomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT norlingmartin genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT bishoprichardp genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT pelleroger genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT qiweihong genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT hensonsonal genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT drabekelliottf genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT tretinakyle genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT odongodavid genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT mwaurastephen genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT njorogethomas genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT bongcamrudlofferik genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT daubenbergerclaudiaa genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence AT silvajoanac genomesofthreestockscomprisingthemostwidelyutilizedlivesporozoitetheileriaparvavaccineexhibitverydifferentdegreesandpatternsofsequencedivergence |